Rectal Cancer Surgery in Patients Older Than 80 Years: Is Hartmann's Procedure Safe?


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 08 09 2020
revised: 23 09 2020
accepted: 24 09 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 22 6 2021
Statut: ppublish

Résumé

The current study aimed to identify the safety and efficacy of Hartmann's procedure (HP) among elderly patients (age ≥80 years) with rectal cancer. Data on surgical outcome, survival rate, and incidence of stoma reversal were retrospectively compared between patients aged over 80 years who underwent anterior resection (AR) and HP. In total, 79 elderly patients underwent rectal cancer surgery. Of these patients, 54 (68.4%) underwent AR and 25 (31.6%) HP. The two groups did not differ significantly in terms of age, nutrient status, and tumor characteristics. Eight (14.8%) patients who underwent AR and six (24.0%) who underwent HP presented with intra-abdominal complications (p=0.35). The overall survival and recurrent-free survival rates between the two groups did not differ. HP for elderly patients with rectal cancer has similar complication rates to AR, and achieved similar oncological outcomes.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The current study aimed to identify the safety and efficacy of Hartmann's procedure (HP) among elderly patients (age ≥80 years) with rectal cancer.
PATIENTS AND METHODS METHODS
Data on surgical outcome, survival rate, and incidence of stoma reversal were retrospectively compared between patients aged over 80 years who underwent anterior resection (AR) and HP.
RESULTS RESULTS
In total, 79 elderly patients underwent rectal cancer surgery. Of these patients, 54 (68.4%) underwent AR and 25 (31.6%) HP. The two groups did not differ significantly in terms of age, nutrient status, and tumor characteristics. Eight (14.8%) patients who underwent AR and six (24.0%) who underwent HP presented with intra-abdominal complications (p=0.35). The overall survival and recurrent-free survival rates between the two groups did not differ.
CONCLUSION CONCLUSIONS
HP for elderly patients with rectal cancer has similar complication rates to AR, and achieved similar oncological outcomes.

Identifiants

pubmed: 33144482
pii: 34/6/3661
doi: 10.21873/invivo.12213
pmc: PMC7811640
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3661-3667

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Br J Surg. 2007 Oct;94(10):1285-92
pubmed: 17661309
Int J Colorectal Dis. 2017 Nov;32(11):1583-1589
pubmed: 28801697
Int J Colorectal Dis. 2011 Apr;26(4):431-6
pubmed: 21221605
Int J Colorectal Dis. 2008 Jul;23(7):703-7
pubmed: 18379795
BMC Cancer. 2009 Feb 26;9:68
pubmed: 19245701
Int J Colorectal Dis. 2007 Aug;22(8):919-27
pubmed: 17260142
Dis Colon Rectum. 2005 Feb;48(2):251-5
pubmed: 15714249
N Engl J Med. 2001 Aug 30;345(9):638-46
pubmed: 11547717
Eur J Surg Oncol. 2018 Nov;44(11):1685-1702
pubmed: 30150158
BMC Surg. 2016 Jul 11;16(1):43
pubmed: 27401339
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Int J Colorectal Dis. 2016 Feb;31(2):189-95
pubmed: 26607905
Int J Colorectal Dis. 2016 Jan;31(1):87-93
pubmed: 26298183
World J Surg. 2001 Mar;25(3):274-7; discussion 277-8
pubmed: 11343175
Ann Surg. 1999 Oct;230(4):544-52; discussion 552-4
pubmed: 10522724
Surg Today. 2019 Feb;49(2):108-117
pubmed: 30151626
World J Surg Oncol. 2014 Nov 23;12:355
pubmed: 25418609
Br J Surg. 2016 Jan;103(2):e106-14
pubmed: 26662377
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Int J Colorectal Dis. 2015 Feb;30(2):181-6
pubmed: 25421100
Tech Coloproctol. 2013 Feb;17 Suppl 1:S41-5
pubmed: 23292110
BJS Open. 2018 Oct 15;3(1):106-111
pubmed: 30734021

Auteurs

Kenta Iguchi (K)

Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan igcknt0802@gmail.com.

Hiroyuki Mushiake (H)

Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.

Seiji Hasegawa (S)

Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.

Daisuke Inagaki (D)

Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.

Tadao Fukushima (T)

Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.

Masakatsu Numata (M)

Department of Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Hiroshi Tamagawa (H)

Department of Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Norio Yukawa (N)

Department of Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Yasushi Rino (Y)

Department of Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Munetaka Masuda (M)

Department of Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH